Given their interrelationship and cyclic response, more in‐depth monitoring of the VEGF, FGF‐2 growth factors and its soluble receptors is needed to clarify their possible pre‐diagnostic role in MM. This evidence concerns the gene FGF2 and Miyoshi myopathy.